Raffles Medical Group Ltd (SGX:BSL)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.8800
-0.0050 (-0.56%)
Aug 6, 2026, 10:10 AM SGT

Raffles Medical Group Cash Flow Statement

Millions SGD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
67.4870.5762.2490.15143.2184.17
Depreciation & Amortization
41.2642.2140.7535.9837.8837.1
Other Amortization
3.222.352.332.272.342.23
Loss (Gain) From Sale of Assets
-0-01.92-0.35-0.020.06
Asset Writedown & Restructuring Costs
-2.62-2.523.09-7.2419.154.64
Stock-Based Compensation
2.873.073.473.413.162.47
Other Operating Activities
-3.85-2.55-6.31-23.822315.27
Change in Accounts Receivable
3.574.88-16.1595.35-32.62-48.33
Change in Inventory
0.59-0.51.70.630.281.21
Change in Accounts Payable
-6.98-3.83-1.54-37.34-6.2361.11
Change in Unearned Revenue
---30.276.08-
Change in Other Net Operating Assets
3.73-12.35-5.25--0.17
Operating Cash Flow
109.28101.3386.25189.31196.23160.11
Operating Cash Flow Growth
7.85%17.48%-54.44%-3.52%22.55%20.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.06-7.87-19.27-20.53-25.01-49.94
Sale of Property, Plant & Equipment
0.010.011.090.520.160.05
Sale (Purchase) of Intangibles
-0.62-2.16-1.64-1.41-0.29-2.86
Sale (Purchase) of Real Estate
------0.07
Other Investing Activities
5.297.529.959.012.310.63
Investing Cash Flow
-3.39-2.51-9.87-12.41-22.83-52.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1.267.67110.9485.6147.01
Total Debt Issued
-0.091.267.67110.9485.6147.01
Long-Term Debt Repaid
--46.34-92.98-122.41-192.19-51.6
Net Debt Issued (Repaid)
-92.58-45.13-25.31-11.47-106.58-4.58
Issuance of Common Stock
0.731.120.287.446.035.6
Repurchase of Common Stock
-12.39-19.92--5.7-24.34-3.23
Common Dividends Paid
-55.21-46.27-44.58-70.68-52.02-37.35
Other Financing Activities
-19.69-20.65-6.6-5.12-6.8-7.31
Financing Cash Flow
-179.14-130.85-76.2-85.52-183.7-46.87

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.36-0.860.95-0.89-1.550.81
Net Cash Flow
-71.89-32.881.1390.49-11.8561.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
101.2293.4666.98168.79171.21110.17
Free Cash Flow Growth
8.30%39.53%-60.31%-1.42%55.40%48.34%
Free Cash Flow Margin
13.67%12.21%8.90%23.84%20.75%15.19%
Free Cash Flow Per Share
0.060.050.040.090.090.06
Levered Free Cash Flow
56.1844.4657.61193.49113.8482.13
Unlevered Free Cash Flow
58.0947.0261.22197.29118.1386.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.14.055.035.126.87.31
Cash Income Tax Paid
23.2322.2925.8421.1429.1521.74
Change in Working Capital
0.92-11.79-21.2588.92-32.514.17